Home Business Development Products Contact A- A A+ Print GLOBAL PRESENCE Africa Morocco Nigeria South Africa Asia Pacific Australia Japan Malaysia Myanmar Sri Lanka Europe France Germany Ireland Italy Lithuania The Netherlands Poland Romania Spain United Kingdom Denmark Finland Hungary Norway Sweden North America Canada USA South America Brazil CIS Russia Ukraine Affiliated Websites Taro Pharmaceutical Industries Limited Dusa Pharmaceuticals About Us Operations Responsibility Investors Media Careers >40 manufacturing sites View our Manufacturing Sites >150 markets served Explore Our Global Operations >2000 marketed products Explore our products >30,000 employees WORLDWIDE Go to Careers Financial Updates 02 DEC FY18 Q2 Financial Result - Transcript 14 NOV FY18 Q2 Financial Press Release 15 SEP FY18 Q1 Financial Result - Transcript Read More Press Releases Board of Directors Acquisitions & Joint Ventures Awards & Accreditations Adverse Event Reporting Research & Development Manufacturing Products Quality Responsibility Sun Pharma - Ranbaxy Merger Ranbaxy Archives Annual Reports Investors Relations Media Kit Press Releases Sitemap Employee Portal Vendors Portal Field Staff Portal U.S. Healthcare Compliance Program Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma's acquisition of Ranbaxy. If you wish to learn more about the program, please click Continue. Copyright © Sun Pharmaceutical Industries Ltd. Privacy Policy | Disclaimer YouTube Twitter Linkdin Site Credits